Skip to main content
Premium Trial:

Request an Annual Quote

No Stomach for Cancer Funds Two Gastric Cancer Genomics Studies

NEW YORK (GenomeWeb) – The non-profit No Stomach for Cancer said today it has awarded $100,000 to fund two research projects that will investigate the genetic basis of gastric cancer.

One of the $50,000 grants will support a project by University of British Columbia Professor David Huntsman and researcher Carla Oliveira, of the Institute of Molecular Pathology and Immunology at the University of Porto, Portugal. Huntsman and Oliveira will team to study the how the CDH1 gene functions in relation to the development of hereditary diffuse gastric cancer. They plan to identify more variants of CDH1 and pinpoint other genes that may be involved in development of HDGC and other types of gastric cancer.

Another $50,000 NSFC grant will fund a study by University of California, Davis Assistant Professor Luis Carvajal-Carmona, at the UC Davis Genome Center, to improve genetic testing options for familial stomach cancer. Current testing for familial stomach cancer is only useful for less than half of families and the genetic causes of the remaining cases are not known, NSFC said. Carvajal-Carmona plans to use DNA sequencing to study families from around the world for whom the cause of their cancer aggregation is not known.

Globally, gastric cancer is the fourth most common type of cancer, and is the second leading cause of cancer deaths, NSFC said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.